enow.com Web Search

Search results

1. EYE - National Vision Holdings, Inc.

   Yahoo Finance

   • News
   •  Charts
   •  Conversations

   • Range :
   • 1d
   • 5d
   • 6m
   • 1y
   • Max

   15.32-0.15 (-0.97%)

   at Tue, Jun 4, 2024, 4:00PM EDT - U.S. markets open in 4 hours 53 minutes

   Nasdaq Real Time Price

   • Ask Price 15.33
   • Bid Price 15.27
   • P/E N/A
   • 52 Wk. High 27.02

   • 52 Wk. Low 13.71
   • Mkt. Cap 1.2B

   • NasdaqGS
   • •Price in USD

2. Results from the WOW.Com Content Network

3. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

   www.aol.com/fda-approves-biosimilars-macular...

   The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related macular degeneration, diabetic retinopathy and other eye conditions. Biosimilars Yesafili and Opuviz...

4. Retinal implant - Wikipedia

   en.wikipedia.org/wiki/Retinal_implant

   A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD).

5. Visual prosthesis - Wikipedia

   en.wikipedia.org/wiki/Visual_prosthesis

   A visual prosthesis, often referred to as a bionic eye, is an experimental visual device intended to restore functional vision in those with partial or total blindness. Many devices have been developed, usually modeled on the cochlear implant or bionic ear devices, a type of neural prosthesis in use since the mid-1980s.

6. Metamorphopsia - Wikipedia

   en.wikipedia.org/wiki/Metamorphopsia

   Metamorphopsia can be a symptom of a number of eye disorders involving the retina or macula. Some of these conditions include the following: Age-related macular degeneration; Epiretinal membrane and vitreomacular traction; Posterior vitreous detachment; Macular hole; Diagnosis

7. Merck to buy eye-focused drug developer EyeBio for as ... - AOL

   www.aol.com/merck-acquire-eye-drug-company...

   It is also being tested in patients with neovascular age-related macular degeneration, a disease which leads to abnormal blood vessel growth in the eye and affects more than 200 million people ...

8. Stem cell therapy for macular degeneration - Wikipedia

   en.wikipedia.org/wiki/Stem_cell_therapy_for...

   Stem cell therapy for macular degeneration. Induced Pluripotent Stem Cell taken from Blood Cell and converted in RPE Cell. Stem cell therapy for macular degeneration is the use of stem cells to heal, replace dead or damaged cells of the macula in the retina. Stem cell based therapies using bone marrow stem cells as well as retinal pigment ...